Last reviewed · How we verify
NCT05077982
The Long Term Effects of COVID on Pulmonary Function
trial testing Spirometry in Covid19 in 123 participants. Completed in 31 January 2022.
31 December 2021
Quick facts
| Lead sponsor | Sciberras, Stephen M.D. |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 123 |
| Start date | 15 October 2021 |
| Primary completion | 31 December 2021 |
| Estimated completion | 31 January 2022 |
| Sites | 2 locations across Malta |
Drugs / interventions tested
- Spirometry
- 6-minute walk
Conditions studied
- Covid19 — all drugs for Covid19 →
- COVID-19 Pneumonia — all drugs for COVID-19 Pneumonia →
- Critical Illness — all drugs for Critical Illness →
- Quality of Life — all drugs for Quality of Life →
Sponsor
Sciberras, Stephen M.D.
Who can join
Adults 18 to 95, any sex, with Covid19 or COVID-19 Pneumonia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
An observational cohort study of patients discharged from the ICU following admission with COVID19 infection, looking at their medical wellbeing 6 months after discharge from the ICU.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05077982
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Spirometry
Trials testing the same drug.
- NCT07351916 — Remission in Adults With Mild-to-moderate Asthma in Thailand · recruiting
- NCT07328035 — Remission in Adults With Severe Asthma in Thailand · recruiting
- NCT07375433 — Heart Failure With Preserved Ejection Fraction in Patients With Сhronic Obstructive Pulmonary Disease: Clinical Course a · recruiting
- NCT07253883 — A Study to Understand the Accuracy of a New Breathing Device Compared to Standard Testing for Asthma and COPD · not yet recruiting
- NCT06626178 — Development of an Artificial Intelligence Model for the Identification and Prevention of Smoking-related Diseases. · NA · recruiting
Other recruiting trials for Covid19
Currently open trials in the same condition.
- NCT03305341 — Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologic Mix · EARLY_PHASE1 · active not recruiting
- NCT06482138 — Dysfunction of Olfaction After COVID-19 Infection: Morphological and Histomolecular Investigation · NA · recruiting
- NCT04924803 — Community Developed Technology-Based Messaging to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs · NA · active not recruiting
- NCT05013632 — COVID-19 International Drug Pregnancy Registry · recruiting
- NCT04806061 — Urine Alkalinisation in COVID-19 · NA · active not recruiting
Other Sciberras, Stephen M.D. trials
Trials by the same sponsor.
- NCT05202769 — Non-Invasive Vital Signs Monitoring (NIVS) Project · unknown
- NCT05035589 — The Effect of Tocilizumab on Procalcitonin and Other Biochemical and Clinical Markers in the Setting of COVID-19 Pneumon · completed
- NCT04206046 — The Effect of Regional Anaesthesia and Genetic Factors in the Development of Chronic Pain Following Total Knee Arthropla · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05077982 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sciberras, Stephen M.D.
- Last refreshed: 12 April 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05077982.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing